Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 2006-2014

  Quattrocelli, Mattia ^a,b   Palazzolo, Giacomo ^a,c,d   Agnolin, Irene ^d   Martino, Sabata ^b   Bouché, Marina ^e   Anastasia, Luigi ^c,d   Sampaolesi, Maurilio ^a,f  

^a Stem Cell Institute   (Belgium)

^b UNIVERSITY OF PERUGIA   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

Author keywords

Bis peroxo vananadium; Cardiomyocytes; iPSCs; microRNAs; Sulfonyl hydrazone

Indexed keywords

BIS PEROXO VANADIUM; HYDRAZONE DERIVATIVE; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 208A; SULFONYL HYDRAZONE 1; UNCLASSIFIED DRUG; VANADIUM;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; HEART MUSCLE CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, DIFFERENTIATION; CASPASE 3; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HYDRAZONES; HYPOGLYCEMIC AGENTS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICRORNAS; MYOCYTES, CARDIAC; SULFONES; TISSUE THERAPY; VANADATES;

MURINAE;

EID: 79960378031     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23118     Document Type: Article

References (25)

1. Barbaric I, Gokhale PJ, Andrews PW,. 2010. High-content screening of small compounds on human embryonic stem cells. Biochem Soc Trans 38: 1046-1050.
2. Blelloch R, Venere M, Yen J, Ramalho-Santos M,. 2007. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1: 245-247. (Pubitemid 47355331)
3. Bostjancic E, Zidar N, Stajer D, Glavac D,. 2010. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115: 163-169.
4. Castaldi L, Serra C, Moretti F, Messina G, Paoletti R, Sampaolesi M, Torgovnick A, Baiocchi M, Padula F, Pisaniello A, Molinaro M, Cossu G, Levrero M, Bouche M,. 2007. Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. FASEB J 21: 3573-3583. (Pubitemid 350075147)
5. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ,. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233. (Pubitemid 43177239)
6. Chen JF, Callis TE, Wang DZ,. 2009. microRNAs and muscle disorders. J Cell Sci 122: 13-20.
7. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R,. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
8. Ivey KN, Muth A, Arnold J, King FW, Yeh RF, Fish JE, Hsiao EC, Schwartz RJ, Conklin BR, Bernstein HS, Srivastava D,. 2008. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2: 219-229. (Pubitemid 351298595)
9. Kaichi S, Hasegawa K, Takaya T, Yokoo N, Mima T, Kawamura T, Morimoto T, Ono K, Baba S, Doi H, Yamanaka S, Nakahata T, Heike T,. 2010. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res 88: 314-323.
10. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ,. 2010. Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290.
11. Kiskinis E, Eggan K,. 2010. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 120: 51-59.
12. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE,. 2007. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25: 1015-1024. (Pubitemid 47517637)
13. Liu N, Olson EN,. 2010. MicroRNA regulatory networks in cardiovascular development. Dev Cell 18: 510-525.
14. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco MA,. 2009. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4: 141-154.
15. Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S,. 2009. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27: 743-745.
16. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ,. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
17. Puceat M,. 2008. Protocols for cardiac differentiation of embryonic stem cells. Methods 45: 168-171. (Pubitemid 351885359)
18. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castella M, Rio P, Sleep E, Gonzalez F, Tiscornia G, Garreta E, Aasen T, Veiga A, Verma IM, Surralles J, Bueren J, Izpisua Belmonte JC,. 2009. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460: 53-59.
19. Sadek H, Hannack B, Choe E, Wang J, Latif S, Garry MG, Garry DJ, Longgood J, Frantz DE, Olson EN, Hsieh J, Schneider JW,. 2008. Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc Natl Acad Sci USA 105: 6063-6068. (Pubitemid 351758399)
20. Takahashi K, Yamanaka S,. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. (Pubitemid 44233629)
21. Takaya T, Ono K, Kawamura T, Takanabe R, Kaichi S, Morimoto T, Wada H, Kita T, Shimatsu A, Hasegawa K,. 2009. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 73: 1492-1497.
22. Takeuchi JK, Bruneau BG,. 2009. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 459: 708-711.
23. Xu C, Police S, Hassanipour M, Gold JD,. 2006. Cardiac bodies: A novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev 15: 631-639. (Pubitemid 44748598)
24. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B,. 2007. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120: 3045-3052. (Pubitemid 47517087)
25. Yokoo N, Baba S, Kaichi S, Niwa A, Mima T, Doi H, Yamanaka S, Nakahata T, Heike T,. 2009. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun 387: 482-488.